Cancer cells disguised as stem cells gain extra resistance
Why are certain cancer cells so resistant? The answer may be that they have either retained or acquired attributes normally found in stem cells.
Mar 27, 2013
0
0
Why are certain cancer cells so resistant? The answer may be that they have either retained or acquired attributes normally found in stem cells.
Mar 27, 2013
0
0
EPFL researchers develop a tool for oncologists using the electrical signature of cancer cells to get just the right treatment dosage for each patient.
Mar 4, 2013
0
0
Bowel cancer cells missing one of three genes can rapidly reshuffle their genetic 'pack of cards' – the chromosomes that hold the cell's genetic information. This reshuffling has been previously shown to render tumours ...
Feb 27, 2013
0
0
A recombinant Newcastle disease virus kills all kinds of prostate cancer cells, including hormone resistant cells, but leaves normal cells unscathed, according to a paper published online ahead of print in the Journal of ...
Feb 25, 2013
0
0
(Medical Xpress)—A molecule already implicated in a number of diverse cellular functions can suppress the growth of tumors in the liver, a Mayo Clinic Cancer Center study has found. Its name is IQGAP1, and when the molecule ...
Feb 13, 2013
0
0
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.
Feb 12, 2013
0
0
Low prediagnostic levels of circulating adiponectin were associated with an increased risk of pancreatic cancer, according to a study published December 14 in the Journal of the National Cancer Institute.
Dec 14, 2012
0
0
A novel approach to identifying potential anticancer drug combinations revealed that pairing cholesterol-reducing drugs called statins with cyclin-dependent kinase inhibitors might provide an effective approach to treating ...
Dec 13, 2012
0
0
One of the most frustrating truths about cancer is that even when a treatment works, it often doesn't work for long because cancer cells find ways to resist. However, researchers reporting studies done in mice in the December ...
Dec 10, 2012
0
0
Despite treatment with imatinib, a successful drug that targets chronic myeloid leukemia (CML), a deadly type of cancer, some patients may continue to be at risk for relapse because a tiny pool of stem cells is resistant ...
Dec 9, 2012
0
0